top of page

CURRENT NEWS

Oct 23, 2023

Alzheimer’s therapy

Vigil Neuroscience has dosed the first subject in a Phase I clinical trial of VG-3927 to potentially treat Alzheimer’s disease (AD).

Read More
Alzheimer’s therapy

Oct 19, 2023

A new Cancer Drug

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

Read More
A new Cancer Drug

Oct 11, 2023

Concierge-Style Services Becoming a Staple In Clinical Trials

Recruit patients faster, retain more of them, and get their outcomes data sooner

Read More
Concierge-Style Services Becoming a Staple In Clinical Trials

Oct 4, 2023

Moderna claims positive results in early study for combo COVID, flu shot

The company is planning to start a Phase 3 trial of the vaccine this year, and is targeting a regulatory approval in 2025.

Read More
Moderna claims positive results in early study for combo COVID, flu shot

Oct 1, 2023

Boundless Bio collaborates with Lilly for Phase I/II solid tumour trial

Boundless Bio has announced a collaboration with Eli Lilly for its first-in-human Phase I/II trial investigating BBI-355 in solid tumours.

Read More
Boundless Bio collaborates with Lilly for Phase I/II solid tumour trial

Mar 18, 2023

Pain points: Unsolved recruitment and trial design issues in pain clinical trials

Although pain affects millions of people worldwide, the industry is still struggling in the ongoing search for safe and effective medication.

Read More
Pain points: Unsolved recruitment and trial design issues in pain clinical trials
bottom of page